rs765524239
Positions:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PM4_SupportingBS2
The NM_003072.5(SMARCA4):c.2066_2068delAGA(p.Lys689del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
SMARCA4
NM_003072.5 disruptive_inframe_deletion
NM_003072.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.27
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_003072.5. Strenght limited to Supporting due to length of the change: 1aa.
BS2
High AC in GnomAdExome4 at 24 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 15/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 14/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.2066_2068delAGA | p.Lys689del | disruptive_inframe_deletion | 15/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.1478_1480delAGA | p.Lys493del | disruptive_inframe_deletion | 11/32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.710_712delAGA | p.Lys237del | disruptive_inframe_deletion | 7/28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.791_793delAGA | p.Lys264del | disruptive_inframe_deletion | 7/27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.551_553delAGA | p.Lys184del | disruptive_inframe_deletion | 6/27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.419_421delAGA | p.Lys140del | disruptive_inframe_deletion | 5/25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152130Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
152130
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251174Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135770
GnomAD3 exomes
AF:
AC:
7
AN:
251174
Hom.:
AF XY:
AC XY:
4
AN XY:
135770
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461606Hom.: 0 AF XY: 0.0000151 AC XY: 11AN XY: 727104
GnomAD4 exome
AF:
AC:
24
AN:
1461606
Hom.:
AF XY:
AC XY:
11
AN XY:
727104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152248Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74440
GnomAD4 genome
AF:
AC:
4
AN:
152248
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 04, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2023 | This variant, c.2066_2068del, results in the deletion of 1 amino acid(s) of the SMARCA4 protein (p.Lys689del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs765524239, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 470279). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jan 30, 2023 | To the best of our knowledge, the variant has not been reported in the published literature. The frequency of this variant in the general population, 0.000098 (3/30602 chromosomes in South Asian subpopulation, http://gnomad.broadinstitute.org), is higher than would generally be expected for pathogenic variants in this gene. Based on the available information, we are unable to determine the clinical significance of this variant. - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 24, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at